DUBLIN, Ohio, Nov. 29 /PRNewswire-FirstCall/ -- Cardinal Health today
announced that the U.S. Drug Enforcement Administration (DEA) will
temporarily suspend its license to distribute controlled substances from
its Auburn, Wash. distribution center effective Dec. 3.
The company said the suspension affects only the Washington facility
and only controlled substance shipments from that facility. Steps are being
taken to ensure continuity of service to its customers.
In an order received today, the DEA said Cardinal Health "failed to
maintain effective controls against the diversion of a particular
controlled substance," and cites the sale of hydrocodone to one pharmacy
that allegedly dispensed excessive amounts of the drug based on
illegitimate prescriptions from Internet pharmacy web sites.
Cardinal Health said the security of the pharmaceutical supply chain is
among its highest priorities, and it will cooperate fully with the DEA to
resolve the suspension.
About Cardinal Health
Headquartered in Dublin, Ohio, Cardinal Health, Inc. (NYSE: CAH) is an
$87 billion, global company serving the health care industry with products
and services that help hospitals, physician offices and pharmacies reduce
costs, improve safety, productivity and profitability, and deliver better
care to patients. With a focus on making supply chains more efficient,
reducing hospital-acquired infections and breaking the cycle of harmful
medication errors, Cardinal Health develops market leading technologies,
including Alaris(R) IV pumps, Pyxis(R) automated dispensing systems,
MedMined(TM) infection surveillance services and the CareFusion(TM) patient
identification system. The company also manufactures medical and surgical
products and is one of the largest distributors of pharmaceuticals and
medical supplies worldwide. Ranked No. 19 on the Fortune 500 and No. 1 in
its sector on Fortune's ranking of Most Admired firms, Cardinal Health
employs more than 40,000 people on five continents. More information about
the company may be found at http://www.cardinalhealth.com.
SOURCE Cardinal Health, Inc.
 back to top
Related links:
http://www.cardinalhealth.com
CONTACT:
Jim Mazzola, +1-614-757-3690,
jim.mazzola@cardinal.com; Investors: Bob Reflogal,
+1-614-757-7542, bob.reflogal@cardinal.com, both of Cardinal
Health, Inc.
|
